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ABSTRACT
Objectives: The present protocol deals with zirconocene dichloride (Cp2ZrCl2) catalyzed synthesis of pyrano[2,3-d]pyrimidinediones through one-
pot multicomponent reactions of aromatic aldehydes with malononitrile and barbituric acid at ambient temperature. All the synthesized compounds 
were characterized and evaluated for antibacterial, antifungal, and antioxidant activities. Furthermore, a molecular docking was carried out to reveal 
the atomic insights between synthesized compounds and carotenoid dehydrosqualene synthase (PDB ID: 3ACX).
Methods: All the synthesized compounds were evaluated for their in vitro antimicrobial activity by diffusion method. Antioxidant activities such as 
1,1-diphenyl-2-picrylhydrazyl and radical scavenging activity. A mixture of barbituric acid 1 (1 mmol), malononitrile 2 (1 mmol), benzaldehyde 3a 
(1 mmol), ethanol (5 mL), and Cp2ZrCl2 (5 mol %) was stirred at ambient temperature for specified time. After completion of reaction as indicated by 
thin-layer chromatography, the obtained crude product was filtered and purified by column chromatography on silica gel (Merck, 60–120 mesh) using 
ethyl acetate:pet. ether to afford pure product which was then characterized by spectroscopic methods such by FTIR, nuclear magnetic resonance (1H 
NMR), 13C NMR, and mass spectroscopy.
Results: All the synthesized pyrano[2,3-d]pyrimidinediones were characterized by spectroscopic analysis. The results revealed that pyrano[2,3-d]
pyrimidinediones (4 a-k) displayed the zone of inhibition in the range of 3–13 mm. The most active compound 4b displayed largest zone of inhibition 
of 13 mm for Escherichia coli (NCIM-2832) and 9 mm for Bacillus subtilis (NCIM-2635). The antifungal and antioxidant activity of all synthesized 
pyrano[2,3-d]pyrimidinediones (4a-k) showed moderate to good activity. Molecular docking studies suggest that pyrano[2,3-d]pyrimidinediones 
might inhibit the carotenoid dehydrosqualene synthase activity.
Conclusion: All the synthesized pyrano[2,3-d]pyrimidinediones display moderate to good antibacterial, antifungal, and antioxidant activity. This 
molecular docking studies supported that pyrano[2,3-d]pyrimidinediones might inhibit the carotenoid dehydrosqualene synthase (PDB ID: 3ACX).
Keywords: Zirconocene dichloride, Pyrano[2,3-d]pyrimidinediones, Antimicrobial, Antioxidant, Carotenoid dehydrosqualene synthase, Molecular 
docking.
INTRODUCTION
Zirconocene represents an important class of organometallic compounds 
in which zirconium is sandwiched between two cyclopentadienyl rings. 
Due to high reactivity and feeble acidity, zirconocenes have attracted 
substantial applications in the area of catalysis [1]. Initially, the 
zirconocene catalyst was limited to the olefin polymerization. However, 
recent reports concerning to successful applications of zirconocene in 
synthetic chemistry have been demonstrated their versatility in organic 
synthesis which has spurred a resurgence of interest in this class of 
compounds [2]. Zirconocene dichloride (Cp2ZrCl2) is an air and moisture 
stable and non-hazardous, d0 zirconocene that has been subject 
of immense interest in catalytic technology due to its Lewis acidic 
character. It is one of the most efficient and widely employed catalysts 
in Ziegler–Natta polymerization [3]. Organometallic Lewis acids play 
an important role in green chemistry and sustainable development [4]. 
Recently, Cp2ZrCl2 has been explored for the synthesis of carbonyl group 
transformation reactions [5], bis(indole)methanes [6], intramolecular 
coupling of alkyne, EtMgBr (ethylene or CO) [7], quinozolin-4(3H)-
ones [8], 1-amidoalkyl-2-naphthols [9], and benzimidazoles [10]. In 
addition, Cp2ZrCl2 has also been employed for acetylation of phenols/
alcohols/amines [11], coupling of terminal alkynes, and intramolecular 
coupling of amines and alkynes. Significant application of zirconium 
in organic synthesis mainly includes Cp2Zr(II) species, the so-called 
zirconocene [12] and Reformatsky and Barbier reactions [13].
Pyrano[2,3-d]pyrimidinediones are heterocyclic scaffolds with 
multifarious biological applications. They are typical annelated uracils 
used in the treatment of B16 melanoma and P388 leukemia [14]. 
In addition, they possess antibronchitic [15], cardiotonic [16], 
antifungals [17], antimalarial [18], antihypertensive [19], 
analgesics [20], and antiviral [21]. Moreover, many of its derivatives 
are used in natural products, carbohydrates, alkaloids, polyether 
antibiotics, pheromones, antihypertensives, cardiotonic, bronchodilator, 
antibronchitic and antitumor activity, anti-inflammatory activity, 
antiallergic, and antibronchitic [22-25]. Due to intriguing structure 
and diverse biological properties, considerable efforts have been 
devoted for the development of efficient methods for the synthesis 
of pyrano[2,3-d]pyrimidinediones [26]. Among several approaches 
developed for this purpose, one-pot multicomponent reaction of 
aromatic aldehydes with active methylene compounds and barbituric 
acid represents the most efficient and powerful process for synthesis 
of pyrano[2,3-d]pyrimidinediones [27]. Several techniques such as 
ultrasound, microwave irradiation, as well as ionic liquids have been 
reported to carry out this reaction [28,29]. However, despite impressive 
progress, there is a still scope to develop new protocol for synthesis of 
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pyrano[2,3-d]pyrimidinediones, especially using metallocene-based 
catalyst related to applications of metallocenes in organic synthesis [30].
Considering aforementioned discussion, we report herein Cp2ZrCl2 
catalyzed synthesis of pyrano[2,3-d]pyrimidinediones and their 
biological activities including molecular docking studies.
MATERIALS AND METHODS
Material and physical measurements
The chemicals and reagents used for the synthesis were obtained from 
commercial sources. All other chemicals and solvents were of analytical 
grade. Fourier transform infrared (FT-IR) spectra were recorded with 
Perkin Elmer FT-IR spectrophotometer (KBr disc, 4000–400 cm−1). The 
samples were examined as KBr discs (ca 5% w/w). Nuclear magnetic 
resonance (1H NMR) and 13C NMR spectra were recorded on a Brucker 
AC (400 MHz for 1H NMR and 100 MHz and 13C NMR) using dimethyl 
sulfoxide (DMSO)-d6 and CDCl3 as solvent and tetramethylsilane (TMS) 
as an internal standard. Chemical shifts are expressed in parts per 
million (ppm) with TMS as an internal reference and coupling constants 
are expressed in hertz (Hz). Mass spectra were recorded in Shimadzu 
QP 2010 GCMS.
Experimental
General procedure for synthesis of pyrano[2,3-d]pyrimidinediones
A mixture of barbituric acid 1 (1 mmol), malononitrile 2 (1 mmol), 
benzaldehyde 3a (1mmol), ethanol (5 mL), and Cp2ZrCl2 (5 mol %) was 
stirred at ambient temperature for specific time. After completion of 
the reaction, as indicated by thin-layer chromatography, the obtained 
crude product was filtered and purified by column chromatography on 
silica gel (Merck, 60–120 mesh) using ethyl acetate:pet. ether to afford 
pure product which was then characterized by spectroscopic methods 
such by FT-IR, 1H NMR, 13C NMR, and mass spectroscopy.
Spectral data of representative compounds
7 -Am i n o - 2 , 4 - d i oxo - 5 - p h e nyl - 2 , 3 , 4 , 5 - te t ra hy d ro - 1 H -
pyrano[2,3-d]pyrimidine-6-carbonitrile (Table 1, Entry a)
Yellow solid; yield: 95%; MP: 223–225°C (Lit. MP 224–226°C) IR 
(KBr cm−1): 3374 (-NH2), 3305, 3215 (-NH), 3117 (C-H), 2131 (-C≡N), 
1698 (-C=O), 1576 (-C=C) cm−1; 1HNMR (400 MHz, DMSO-d6); δ =10.99 
(s, 1H, NH); 10.83 (s, 1H, NH); 7.34 (t, J = 7.6 Hz, 2H, Ar-H); 7.18–7.09 
(m, 3H, Ar-H), 6.86 (s, 2H, NH2), 4.28 (s, 1H, CH) ppm. 13C NMR 13CNMR 
(100 MHz, DMSO-d6); δ =161.38, 144.95, 128.69, 128.47, 128.65, 
118.25, 50.86, ppm; Ms (m/z):283.09 [M+H]+.
7-Amino-S-(3-nitrophenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-
pyrano[2,3-d]pyrimidine-6-carbonitril (Table 1, Entry b)
White powder, yield 85%; MP: 256–257°C (Lit. MP 263–264°C) IR 
(KBr cm−1): 3317 (NH2), 3306, 3248 (NH), 2945 (C-H), 2214 (C=N), 
1609 (C=O), 1476 (C=C). 1HNMR (400 MHz, DMSO-d6); δ = 12.05 
(s, 1H, NH), 10.25 (s, 1H, NH) 8.37 (s, 1H, Ar-H), 8.24 (d, J = 6.4 Hz, 
2H, Ar-H), 6.85 (s, 2H, NH2); 3.95 (s, 1H, CH) ppm; 13CNMR (100 MHz, 
DMSO-d6); δ = 166.12, 160.73, 157.01, 151.56, 150.57, 146.11, 
129.23, 123.08, 119.45, 104.42, 79.32, 71.10 ppm; Ms (m/z): 328.2 
M+Hj.
7-Amino-S-(4-bromophenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-
pyrano[2,3-d]pyrimidine-6-carbonitril (Table 1, Entry f)
White powder yield: 87% MP 236–239°C (Lit MP 235–238°C) IR 
(KBr, υ cm−1): 3376 (NH2) 3347, 3193 (NH), 3085 (C-H) 2225 (C=N), 
1685 (C=O), 1568 (C=C). 1H NMR (400 MHz, DMSO- d6): δ = 14.16 (s, 
1H, NH), 13.04 (s, 1H, NH), 7.78 (d, J = 7.2 Hz, 2H, Ar-H), 7.36 (d, J 
7.2 Hz, 2H, Ar-H) 6.87 (s, 2H, NH2) 3.97 (s, 1H, CH) ppm; 13CNMR (100 
MHz, DMSO-d6): δ = 173.49, 160.39, 153.97, 145.96, 138.56, 131.97, 
129.69, 124.07, 121.32, 105.28, 69.65, 50.14. ppm; Ms (m/z): 384.15 
(M+Na).
7-Amino-5-(4-nitrophenyl)-2,4-dioxo-2,3,4,5-tetrahydro-1H-
pyrano[2,3-d]pyrimidine-6-carbonitrile (Table 1, Entry g)
White powder, MP: 234–238°C (Lit. Mp: 238–239°C) yield: 95% 
IR (KBr ɤ cm−1): 3415 (-NH2), 3208, 3166 (-NH) 2988 (-CH), 
2208 (-C≡N), 1737 (-C=O), 1465 (-C=C),1HNMR (400 MHz, 
DMSO-d6): δ = 13.04 (s, 1H, NH): 8.97 (s, 1H, NH), 7.97 (d, J = 7.2 Hz, 2H 
Ar-H) 7.47 (d J = 7.2 Hz, 2H, Ar- H), 6.77 (s, 2H, NH2), 4.98 (s, 1H, CH) 
ppm; 13CNMR (100 MHz, DMSO-d6): δ = 177.48, 170.61, 153.96, 153.80, 




1,1-diphenyl-2-picrylhydrazyl (DPPH) radical scavenging activity 
(RSA) of synthesized pyrano[2,3-d]pyrimidinediones (4 a-k) was 
determined using DPPH assay as described by Lee et al. [31] with slight 
modification. In short, the stock reagent DPPH solution was prepared 
by dissolving 24 mg of DPPH in 100 mL methanol and stored at −20°C 
for further use. The working reagent was prepared by adding 10 mL 
of stock DPPH solution with 45 mL methanol, to obtain an absorbance 
1.1±0.02 O. D. at 517 nm using spectrophotometer. The extracted 
samples with known concentrations were allowed to react with 3 mL 
of DPPH solution. The reaction mixture was then incubated in dark 
condition at room temperature for 3 h and absorbance was measured 
at 517 nm. A control sample with no added extract was analyzed and 
the results are expressed as RSA in percent.
% RSA = (Acontrol-Asample) ×100/Control
Where, A = absorbance at 517 nm.
Ferric reducing/antioxidant power (FRAP) assay
The ferric reducing power of synthesized pyrano[2,3-d]
pyrimidinediones (4 a-k) was investigated using the method of Benzie 
and Strain with a slight modification [32]. The working FRAP reagent 
was prepared by the addition of 300 mM acetate buffer (pH 3.6), 2, 4, 
6-tripyridyl-s-triazine (10 mm) in 40 mm HCl and 20 mm FeCl3 6H2O 
in 10:1:1 ratio and heated at 37°C in water bath for 10 min. Respective 
samples with known concentrations were allowed to react with 2.7 mL 
of the FRAP reagent. The final volume of the reaction mixture was 
adjusted to 3 mL with D/W. The reaction mixture was then incubated 
at room temperature for 30 min in dark condition and absorbance was 
measured spectrophotometrically at 593 nm, and the results were 
directly expressed in terms of increase in O. D.
Antifungal activity
The antifungal activity of synthesized pyrano[2,3-d]pyrimidinediones 
(4 a-k) was investigated using strains such as Candida albicans (NCIM-
3466) and Saccharomyces cerevisiae (NCIM-3495). The inoculums 
of C. albicans (NCIM-3466) and S. cerevisiae were spread on the 
sterile potato dextrose agar (PDA) plates. The wells in PDA plates 
were prepared with the help of sterile steel borer. The pyrano[2,3-d]
pyrimidinediones (4 a-k) were added in each respective wells, and then, 
these plates incubated at 37°C for 24 h. The results were assessed after 
completion of incubation time.
Antimicrobial activity
The synthesized pyrano[2,3-d]pyrimidinediones (4 a-k) were assessed 
for their antimicrobial activity against bacterial strains, namely Bacillus 
subtilis (NCIM-2635) and Escherichia coli (NCIM-2832), as per earlier 
methodology [33]. Inoculums of target bacterial cells were prepared 
using sterile saline water. These inoculums were then spread on a 
sterile nutrient agar plats using spread plate techniques sterile steel 
borer was used to prepare wells in the plates. Finally, pyrano[2,3-d]
pyrimidinediones (4 a-k) were added in each wells containing B. subtilis 
(NCIM-2635) and E. coli (NCIM-2832), respectively. All the plates were 
incubated at 37°C for 24 h.
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Table 1: Cp2ZrCl2 catalyzed synthesis of pyrano[2,3‑d] pyrimidinedionesa
Entry Aldehyde (3) Product (4) Time (min) Yieldb (%) Melting point observed (°C) Melting point (Lit.) (°C)
a 30 95 223–225 224–226 [31]
b 30 85 261–263 263–264 [31]
c 40 80 259–261 261–264 [31]
d 35 87 160–162 163–164 [27]
e 40 85 168–170 170–174 [30]
f 30 87 235–237 235–238 [20]
g 30 95 235–238 238–239 [26]
h 30 88 287–288 289–293 [30]
i 40 87 230–234 230–231 [41]
(Contd...)
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RESULTS AND DISCUSSION
Our initial studies were directed toward the optimization of reaction 
conditions. In this context, multicomponent reaction between barbituric 
acid 1 (1 mmol), malononitrile 2 (1 mmol), and benzaldehyde 3a (1 mmol) 
was chosen as a model reaction. To obtain the best results, the model 
reaction was examined in the presence of various quantities of Cp2ZrCl2 
in ethanol. In the presence of 5 mol% Cp2ZrCl2, the reaction proceeded 
smoothly furnishing desired 7-amino-2,4-dioxo-5-phenyl-2,3,4,5-
tetrahydro-1H-pyrano[2,3-d]pyrimidine-6-carbonitrile (4a) in 85% yield. 
When the quantity of Cp2ZrCl2 was increased from 5 mol% to 10 mol%, 
the yield of corresponding product was elevated from 90 to 95% (Table 2, 
entry 1 and 2). However, further increase in catalyst quantity beyond 10% 
did not significantly influence yield of the product (Table 2, entries 3, 4).
Next, we investigated the solvent effect on the model reaction by 
employing an array of solvents. Good yields were obtained in polar 
protic solvents such as methanol and ethanol (Table 3, entries 1, 2), 
while comparatively lower yields were obtained in non-polar solvents 
such as CH3CN, CH2Cl2, 1,4-dioxane, CHCl3, and toluene (Table 3, entries 
3-7). The reaction could not be initiated to synthetically useful degree 
in DMF (Table 3, entry 8). Among all the screened solvents, ethanol was 
found to furnish excellent yield of the corresponding product in shorter 
reaction time (Table 3, entry 2).
After optimization of reaction conditions, we investigated the scope 
of reaction by reacting barbituric acid 1 (1 mmol) and malononitrile 
2 (1 mmol), with structurally diverse aldehydes (3 a-k). The results 
are summarized in Table 1. The present methodology is flexible to the 
presence of different functional groups on aromatic ring in aryl aldehydes 
and provided the anticipated products in moderate to excellent yields. 
It is noteworthy to mention that aryl aldehydes possessing electron 
withdrawing as well as electron-donating substituents did not affect 
the product yield.
The plausible mechanism for the formation of pyrano[2,3-d]
pyrimidinediones (4 a-k) using Cp2ZrCl2 is depicted in Scheme 1. 
Initially, Cp2ZrCl2 activates carbonyl group of aryl aldehyde through 
coordination of Zr with carbonyl oxygen [8]. This facilitates nucleophilic 
attack of malononitrile on carbonyl group, leading to the formation of 
2-benzylidenemalonitrile, on which there is a conjugate addition of 
barbituric acid, leading to the formation of a cyclic imine intermediate 
that undergoes subsequent cyclization furnishing the desired product.
To compare the applicability and efficiency of present protocol with 
reported methods for the synthesis pyrano[2,3-d]pyrimidinediones, we 
have summarized the results of Cp2ZrCl2 with reagents (Table 4). The 
results reveal that Cp2ZrCl2 is better catalyst both in terms of reaction 
time and yield of the products.
Antimicrobial and antioxidant activity
The antimicrobial activity of pyrano[2,3-d]pyrimidinediones (4a-k) was 
examined using agar gel diffusion method. The antimicrobial activity 
performed against Gram-negative (E. coli NCIM-2832) and Gram-positive 
(B. subtilis NCIM-2635) bacterial strains. The clear zones of inhibition were 
observed around the wells of B. subtilis (NCIM-2635) and E. coli (NCIM-2832) 
plates (Fig. 2). The results revealed that pyrano[2,3-d]pyrimidinedione 
(4a-k) displayed the zone of inhibition in the range of 3–13 mm (Fig. 2 
and Table 5). The most active compound 4b displayed having largest zone 
of inhibition of 13 mm for E. coli (NCIM-2832) and 9 mm for B. subtilis 
(NCIM-2635) (Fig. 2 and Table 5). Hence, antibacterial, of all the screened 
synthesized compounds pyrano[2,3-d]pyrimidinediones, showed 
moderate to excellent activity against these bacteria. The antioxidant 
potential of synthesized derivatives of pyrano[2,3-d]pyrimidinedione was 
Table 2: Optimization of catalyst loading in the synthesis of 
pyrano[2,3‑d] pyrimidinediones
Entry Cp2ZrCl2 (mol %) Time (min) Yield (%)
1 5 35 95
2 10 25 90
3 15 30 91
4 20 35 93
*Optimal condition: Barbituric acid 1 (1 mmol), malononitrile 2 (1 mmol), and 
benzaldehyde 3a (1 mmol) in ethanol (5 mL) at ambient temperature
Table 3: Optimization of solvent loading in the synthesis of 
pyrano[2,3‑d] pyrimidinediones
Entry Solvent Time (min) Yield (%)
1 Methanol 45 75
2 Ethanol 30 95
3 CH3CN 45 55
4 CH2Cl2 55 65
5 1,4-Dioxane 90 55
6 CHCl3 55 62
7 Toluene 90 45
8 DMF 70 34
*Optimal condition: Barbituric acid 1 (1 mmol), malononitrile 2 (1 mmol), and 
benzaldehyde 3a (1 mmol) in solvent (5 mL) at ambient temperature
j 40 89 216–218 215–217 [41]
k 35 90 309–310 303–306 [27]
*Optimal condition: Barbituric acid 1 (1 mmol), malononitrile 2 (1 mmol), and benzaldehyde 3a (1 mmol) in solvent (5 mL) at ambient temperature
Table 1: (Continued)
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determined using simple, rapid, and inexpensive assays. The synthesized 
derivatives show strong DPPH, RSA, and FRAP activity.
The synthesized pyrano[2,3-d]pyrimidinediones (4a-k) were 
tested for antimicrobial activity against bacterial strains, namely 
B. subtilis (NCIM-2635) and E. coli (NCIM-2832) as per earlier 
methodology [33] and zone of clearance around the wells inoculated 
with the pyrano[2,3-d]pyrimidinediones. The antifungal potential of 
pyrano[2,3-d]pyrimidinedione derivatives (4 a-k) was examined by the 
agar gel diffusion method. These results indicate that pyrano[2,3-d]
pyrimidinediones derivative (4 a-k) also shows decent antibacterial 
activity against E. coli (NCIM-2832) and B. subtilis (NCIM-2635) 
(Table 5).
Antifungal testing was carried out against C. albicans (NCIM-3466) 
and S. cerevisiae (NCIM-3495) (Table 6). These results suggest that 
pyrano[2,3-d]pyrimidinediones derivative (4 a-k) also depicts good 
antifungal activity against C. albicans (NCIM-3466) and S. cerevisiae 
(NCIM-3495).
Molecular docking
Molecular docking studies have been found useful to understand 
interactions between enzymes and ligands [34-37]. Thus, molecular 
docking studies were carried out between carotenoid dehydrosqualene 
synthase (PDB ID: 3ACX) and pyrano[2,3-d]pyrimidinediones using 
Patch dock server [38,39]. The carotenoid dehydrosqualene synthase 
has been used as a target for pyrano[2,3-d]pyrimidinediones due to its 
important role in bacterial cell for the production of the C30 carotenoid 
backbone, that is, dehydrosqualene [40].
Three-dimensional models of pyrano[2,3-d]pyrimidinediones were 
constructed using SPARTAN versus 6.0.1 Software [41]. Then, energy 
minimization was carried out by Hartree–Fock method [42]. Further, 
Scheme 1: Proposed mechanism for the synthesis of pyrano[2,3‑d]pyrimidinediones using Cp2ZrCl2
Fig. 2: Plate containing (a) Bacillus subtilis (NCIM‑2635) and 
(b) Escherichia coli (NCIM‑2832) showing the clear zone around 





Fig 1: Radical scavenging activity (RSA) of pyrano[2,3‑d]
pyrimidinediones (a) 1,1‑diphenyl‑2‑picrylhydrazyl RSA in 
(b) ferric reducing antioxidant power expressed in O. D. at 593 nm
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the minimized structures of pyrano[2,3-d]pyrimidinediones were 
used to dock with carotenoid dehydrosqualene synthase (PDB ID: 
3ACX) [38]. All the docked complexes were analyzed with the help 
of CHIMERA [43]. The residues of carotenoid dehydrosqualene 
synthase (PDB ID: 3ACX) forming hydrogen bonding interactions 
with pyrano[2,3-d]pyrimidinediones were studied by CHIMERA [43]. 
Similarly, the earlier reports suggested that chemically synthesized 
molecules can be further used for their activity against several 
enzymes [44,45]. Docking energy values for all the synthesized 
compounds along with standard ciprofloxacin are shown in Table 7. 
The negative docking energy indicates the proper binding mode 
of compounds within the active site of dehydrosqualene synthase 
(Table 7). The binding mode of the most potent compounds 4b, 4f, 4i, 
and 4k is shown in Fig. 3. These compounds are exhibit in hydrogen 
bonding interactions with the active site residues of carotenoid 
dehydrosqualene synthase. The H-bond interactions of compound 4b 
with the active site residues of dehydrosqualene synthase are shown 
in Fig. 3a. The compound 4b interacts with oxygen atom of TYR 248 
and NH2 group of ASN 168 with bond distances 2.397 and 2.183 Å, 
respectively (Table 8, entry 4a and 4b). The compound 4f has hydrogen 
bonding interactions with the oxygen atom of ASP 176 (Fig. 3b) with 
a bond distance 3.083 Å (Table 8, entry 4c and 4d). The compound 4i 
forms hydrogen bonding interactions with the oxygen atoms of ASP 176 
and ASP 48 (Fig. 3c) with the interatomic distances 1.993 and 1.745 
Å, respectively (Table 8, entry 4e and 4f), indicating strong hydrogen 
bonding interactions with the active site residues of dehydrosqualene 
synthase. The compound 4i interacts with dehydrosqualene synthase 
by hydrogen bonding interactions with hydroxyl group of TYR 248 and 
NH2 group of ARG 265 (Fig. 3d) with the bond distances 2.051 and 
2.936 Å (Table 8, entry 4g, 4h, and 4i). The docking studies revealed 
Table 4: Comparison of catalytic activity of Cp2ZrCl2 with reported catalyst
Entry Catalyst Solvent Quantity Temp (°C) Time Yield (%) References
1 L-Proline EtOH 17 mol% Reflux 30 min 80 [18]
2 H14[NaP5W30O110] EtOH 1 mol% Reflux 30–60 min 85 [22]
3 SBA-PrSO3H Solvent Free 0.02 g 140 45 min 91 [20]
4 [BMIM] BF4 [BMIM] BF4 1.5 g 90 5 h 82 [21]
5 DAHP EtOH (10 mol%) R.T. 2 h 71 [17]
6 Cp2ZrCl2 EtOH 5 mol% R.T. 30 min 95 This work
Table 5: Zone of clearance around the wells inoculated with the pyrano[2,3‑d] pyrimidinediones in the (b) Escherichia coli (NCIM‑2832) 
plates and Bacillus subtilis (NCIM‑2635)
Entry Compound Zone of Clearance in mm Escherichia coli (NCIM‑2832) Zone of clearance in mm Bacillus subtilis (NCIM‑2635)
1 4a 4 3
2 4b 13 9
3 4c 9 11
4 4d 5 5
5 4e 1 1
6 4f 8 9
7 4g 7 8
8 4h 5 9
9 4i 7 7
10 4j 8 9
11 4k 8 5
12 Ciprofloxacin 16 17
Table 6: Zone of clearance around the wells inoculated with the pyrano[2,3‑d] pyrimidinediones in the Candida albicans (NCIM‑3466) 
and Saccharomyces cerevisiae (NCIM‑3495)
Entry Compound Zone of clearance in mm Candida albicans 
(NCIM‑3466)
Zone of clearance in mm Saccharomyces cerevisiae 
(NCIM‑3495)
1 4a 5 7
2 4b 14 11
3 4c 12 13
4 4d 7 9
5 4e 8 10
6 4f 7 12
7 4g 10 9
8 4h 13 11
9 4i 9 14
10 4j 12 8
11 4k 7 11
Table 7: Molecular docking between pyrano[2,3‑d] 
pyrimidinediones and carotenoid dehydrosqualene synthase




1 4a −1178.6541620 470.00
2 4b 1178.6614029 491.70
3 4c −1178.6943076 471.40
4 4d 1049.6561871 473.80
5 4e −1049.6517024 437.70
6 4f −3534.9100575 452.90
7 4g −975.2209925 458.10
8 4h −1088.4677932 456.60
9 4i 1088.4640411 491.10
10 4j −1432.0428743 440.90
11 4k −3534.9103618 459.60
12 Ciprofloxacin −1135.2195612 524.00
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Table 8: Hydrogen bonding interactions between carotenoid dehydrosqualene synthase with pyrano[2,3‑d] pyrimidinedione derivatives
Entry Sr. 
No.
Interaction between active site residues of carotenoid 
dehydrosqualene synthase with pyrano[2,3‑d] 
pyrimidinedione derivatives (4B, 4F, 4I, and 4K)
Distance 
in Å
1 4a SER 21.A OG ------ 4B.het H: 0.839
2 4b 4B.het H ------ ASN 168.A ND2: 2.183
3 4c 4F.het H ------ ARG 265.A NH2: 1.592
4 4d ASP 48.A OD1 ------ 4F.het Br: 2.254
5 4e 4I.het H ------ ASP 176.A OD1: 1.993
6 4f ASP 48.A OD2 ------ 4I.het C: 1.177
7 4g ASP 48.A OD2 ------ 4I.het C: 1.745
8 4h 4K.het H ------ TYR 248.A OH: 2.051
9 4i ARG 265.A NH1 ------ 4K.het O: 2.936
that the compounds 4b, 4k, 4f, and 4i interact strongly with the active 
site residues of dehydrosqualene synthase, indicating their proper 
binding. The studies suggest that compounds 4b, 4k, 4f, and 4i are likely 
to inhibit the carotenoid dehydrosqualene synthase enzyme present in 
the bacteria. The docking results are inconsistent with the observed 
antimicrobial activities.
CONCLUSION
We have reported one-pot multicomponent synthesis of pyrano[2,3-d]
pyrimidinediones from aromatic aldehydes, malononitrile, and 
barbituric acid at ambient temperature using catalytic amount of 
Cp2ZrCl2. The present protocol grants advantages including high yields, 
effective simplicity, less reaction time, and smooth reaction conditions. 
In addition, the biological screening of pyrano[2,3-d]pyrimidinediones 
suggests good antimicrobial potential. Further, molecular docking 
studies of pyrano[2,3-d]pyrimidinediones reveal hydrogen bonding 
interactions of these compounds with the active site residues of 
carotenoid dehydrosqualene synthase enzyme present in the bacteria.
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